Statistics for Mrna vaccines against sars-cov-2: advantages and caveats

Total visits

views
Mrna vaccines against sars-cov-2: advantages and caveats 92

Total visits per month

views
March 2025 1
April 2025 0
May 2025 2
June 2025 0
July 2025 0
August 2025 0
September 2025 0

File Visits

views
Echaide_mRNAVaccines.pdf 206

Top country views

views
United States 50
Sweden 4
Spain 3
Malaysia 3
Saudi Arabia 3
Canada 2
China 2
Italy 2
South Korea 2
Singapore 2
Ethiopia 1
Israel 1
India 1
Kazakhstan 1
Taiwan 1

Top city views

views
Oakland 16
Ann Arbor 5
San Diego 5
Mountain View 3
Bartlesville 2
Beijing 2
Kuala Lumpur 2
New York 2
Singapore 2
Tempe 2
Umeå 2
Asheville 1
Chatham 1
Irvine 1
Jacksonville 1
Jerusalem 1
Kyoto 1
Leawood 1
London 1
Madrid 1
Menlo Park 1
New Port Richey 1
Portland 1
Salt Lake City 1
Seoul 1
Sevilla 1
Stanford 1
Tokyo 1
Wilmington 1